ANSTO Corporate Plan 2024-2028

Corporate Plan

2024 - 2028

ANSTO vision

Nuclear science and technology for the benefit of all Australians

Introduction A message from the Chair of the Board

On behalf of the ANSTO Board, I present ANSTO’s 2024-2028 Corporate Plan, as required under section 35(1)(b) of the Public Governance, Performance and Accountability Act 2013 (Cth).

ANSTO ensures access to our scientific infrastructure and facilities to advance Australia’s nuclear science, technology, and research. Our scientific capabilities and expertise provide societal benefits, whilst also addressing Government priorities and supporting industry. ANSTO’s impact extends across the fields of the environment, where research informs climate change management; health, where we improve diagnostics and treatments of diseases; nuclear technologies, including the development of detector technologies for national security; and additional public benefits in a range of areas, such as better food provenance to protect native food industries from fraudulent products.

Currently, ANSTO is ramping up investment in research, development, and production in a range of areas. These include safeguarding Australia’s supply of life-saving nuclear medicine, strengthening research on metals and minerals, and contributing to international environmental research.

ANSTO’s research strategy aims to improve not only the health and wellbeing of Australians, but also global health. For example, ANSTO scientists, with local and international collaborators, recently made significant progress on a new approach to cancer treatment, Neutron Capture Enhanced Particle Therapy (NCEPT), with the potential to improve outcomes for patients with difficult to treat cancers, such as brain tumours. Their work will continue to benefit global health as they research and explore its potential for clinical translation.

We have focussed on improving international partnerships, where ANSTO’s work in global and regional technical cooperation, including with the International Atomic Energy Agency (IAEA) has stimulated collaboration in nuclear science and technology. As the representative for Australia, ANSTO used its time as Chair of the IAEA Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) to share its insights in areas such as nuclear security, health, climate change, and food provenance.

With over 70 years of nuclear science and accelerator experience, ANSTO is home to world-class researchers, scientists, engineers, and nuclear experts. Nuclear science and technology will be increasingly important to Australia’s economic and social prosperity, so it is essential that we continue to invest in our people to develop the STEM workforce of the future.

I hope that this Corporate Plan will provide an increased understanding and appreciation of the role that ANSTO and its staff and researchers can play in advancing Australia’s interests.

Board Chair

A message from the Chief Executive Officer

ANSTO’s Corporate Plan outlines our strategy for delivering the benefits of nuclear science for all Australians. We are always seeking to improve our facilities and capabilities in the areas of human health, the environment, advanced manufacturing, net zero, defence, and national security challenges.

The important announcement of Federal Government funding in the 2023/24 budget supports ANSTO’s critical sovereign capability in the current and future production of life-saving nuclear medicines and provides a focus for one of our key sovereign capabilities. The plans for a new Nuclear Medicine Manufacturing Facility (NMMF) will consider the current and future needs of our nuclear medicine clinicians so they can deliver world leading healthcare across Australia. I am proud of ANSTO’s commitment to guaranteeing supply of these life-saving nuclear medicines, which enable between 10,000 – 12,000 procedures at Australian hospitals and medical clinics each week.

Through our extraordinary people capability and research infrastructure, we support both industry and visiting researchers as they tackle some of the biggest challenges. In alignment with our research priorities, our capabilities facilitate innovations in industry, improvements in health, novel methods for protecting the environment, conservation of Indigenous heritage, verification of food provenance, enhancement of nuclear fuel cycle technologies, and new scientific discoveries. Our landmark infrastructure provides us the instruments to carry out this research and is critical for delivering knowledge and advancing prosperity for Australia.

Internationally, ANSTO spearheads Australia’s involvement in nuclear policy, engaging with pivotal multilateral platforms such as the International Atomic Energy Agency, the Nuclear Energy Agency of the OECD, and the Generation IV International Forum. As ANSTO concludes its major role as Chair of the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA), a treaty level agreement between 22 countries under the International Atomic Energy Agency (IAEA), we will continue to steer international cooperation on the Committee of Chairs.

Looking to the horizon, we anticipate new opportunities for cooperation stemming from the AUKUS partnership and the projected expansion of Australia’s nuclear workforce, driven by demands for nuclear capabilities. Central to these capabilities are our people, and we are steadfast in our commitment to cultivate a future nuclear workforce that is diverse, inclusive, and highly skilled.

I am confident that in the years ahead ANSTO will continue its tradition of providing invaluable knowledge, value, and trust to the Australian Government and its citizens. Through the application of nuclear science and technology, we remain dedicated to delivering substantial social and economic benefits to every corner of Australia.

Shaun Jenkinson Chief Executive Officer

Our organisation

Our mission

To deliver knowledge, value and trust through the application of nuclear science, technology and engineering .

What we do

ANSTO operates Australia’s only nuclear reactor, and we address some of the most challenging issues facing Australia in the fields of health, environment, advanced manufacturing, defence, and national security. Our work supports the growth of sovereign capability in nuclear science and technology, and areas such as nuclear medicines and critical minerals.

ANSTO produces 80 per cent of Australia’s nuclear medicines, used for the diagnosis, staging, and treatment of diseases, including cancer. Our sovereign production of nuclear medicine will be further enhanced by the upcoming construction of the new Nuclear Medicine Manufacturing Facility (NMMF).

We also support scientific research in collaboration with Australian and international research organisations through access to world class science infrastructure, such as the Australian Synchrotron, the Australian Centre for Neutron Scattering, the Centre for Accelerator Science, and the National Deuteration Facility.

In terms of the environment, our research is contributing to improvements in water sustainability, air quality, and understanding the impact of contaminants.

We facilitate education and training in nuclear science and technology in collaboration with universities, vocational institutes, and a range of both government and industrial partners.

For industry, we provide research, advice, and products in areas such as critical minerals to support a more competitive Australia.

In advanced manufacturing our research is addressing issues such as: the development of novel functional materials, improving battery storage, as well as silicon irradiation for high-tech applications in greener power grids, high-speed rail, industrial automation, electric vehicles, and satellites.

In defence and national security, we provide our nuclear knowhow and expertise to support the optimal pathway for the acquisition of nuclear-powered submarines, radiation detection, and safety training for other organisations.

ANSTO is also progressing opportunities to collaborate with other Commonwealth agencies in graduate programs and other early career initiatives to build the nuclear capable and STEM-enabled workforce to support these initiatives.

Our capabilities

To create solutions for Australia, ANSTO operates much of Australia’s world class nuclear infrastructure including one of the world’s most modern multi-purpose reactors, OPAL; a comprehensive suite of instruments at the Australian Centre for Neutron Scattering; the Australian Synchrotron; and the Centre for Accelerator Science. We support and deliver nuclear science enabled research and enable technological developments directly through our internal research, and indirectly, by making our research infrastructure accessible to external users from universities, research institutions, and industry, from around Australia and internationally.

ANSTO continues to expand and enhance capability to advance the national interest, concentrating our research and development efforts around areas that deliver against national priorities against which ANSTO is uniquely positioned to deliver. This includes:

Nuclear Science and Landmark Infrastructure applied to:

. Nuclear medicines

Research and development of critical minerals and metals

. Nuclear forensics

. Irradiation services

. Radiation services

. Nuclear waste solutions

. Development of materials for advanced manufacturing

. National space payload testing

. Molecular deuteration

Developing current and future nuclear technologies for Australia

. Radiopharmaceuticals and radioisotopes –diagnostics, therapeutics, theranostics

. Detection and imaging

Providing Australia with nuclear expertise, advice, and services to support:

. Radioactive waste management

Australian Government-policy making

. Nuclear international dialogue

. Training programs

. AUKUS trilateral security partnership

. Radiological safety

. Building national research capacity and capabilities

Supporting the development of a nuclear capable workforce development

. Graduate Institute

. Early careers

. Nuclear safety technician development program

With over 70 years of nuclear science and accelerator experience, ANSTO is home to world-class researchers, scientists, engineers, and nuclear experts. Nuclear science and technology contributes to the wellbeing of all Australians and the strength of Australia’s sovereign capabilities. It is vitally important that we continue to invest in our people and the wider national capability to develop the STEM workforce of the future. ANSTO plays a pivotal part in

this expansion and in developing STEM careers through our early career pathways/programs and through the upskilling of the existing workforce. The recent expansion of Australia’s nuclear capability to include naval propulsion will require a growing and diverse workforce with a broad range of skills. We will be crucial in securing a sovereign nuclear capability for Australia’s future.

1,439.6

Our purpose

ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertake for the benefit of Australia, to:

. Conduct research and development in relation to nuclear science, engineering and technology;

Produce and use radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture;

. Encourage and facilitate the application and use of results gained from research and development;

Manage radioactive materials and waste arising from various prescribed activities;

. Provide goods and services related to core activities, such as in connection with the production and use of radioisotopes;

Provide advice to government and liaise with other countries on behalf of Australia in nuclear-related matters;

. Make available to other persons – whether or not on a commercial basis – the knowledge, expertise, equipment, facilities, resources and property of the organisation for the purposes of scientific research, innovation and training;

. Publish scientific and technical reports, periodicals and papers, and provide public information and advice; and

. Facilitate education and training in nuclear science and technology, including through granting scientific research studentships and fellowships, in cooperation with universities, professional bodies and other education and research institutions.

Our values

Our values were developed by our staff and underpin everything we do.

Our commitment to safety and community

ANSTO is committed to our core values of Safe, Secure and Sustainable. It is essential that we protect, promote, and enhance the physical and psychological health and wellbeing of our people, as well as our community and the environment. We acknowledge that we all have a role to play in protecting our people, community, and the environment - when we see something, we say something.

Safety is integrated into every aspect of ANSTO’s organisation. We encourage and train our staff in hazard identification, risk assessment, selecting and implementing controls, and developing safe work environments. We are constantly pursuing improvement, consulting with stakeholders to mitigate safety risks, and proactively fulfilling legal and regulatory obligations.

As part of our commitment to safety and our community, we seek to continually contribute to the health, wellbeing, economic, and social development of our communities by building relationships based on trust and care. To this end, ANSTO is committed to its relationships with Aboriginal and Torres Strait Islander communities. We consult with our Traditional Custodians to develop and deliver cultural awareness training for our staff, and simultaneously deliver outcomes for our Indigenous communities on issues that directly affect them.

2.7.1

Safety culture

Safety is embedded in ANSTO’s culture and ANSTO maintains the highest safety standards across the organisation. Our safety culture includes programs in physical, psychological and social safety.

HEALTH MONITORING PROGRAM

With a strategic goal to improve the visibility of occupational health performance at ANSTO, the successful implementation of major new software platforms has ensured compliance with health monitoring records and enhanced reporting of worker health metrics, while ongoing efforts involve transitioning ANSTO’s External Dosimetry Database to Historion for improved reporting practices and replacing the existing official dosimetry system with newer technology.

ANSTO expertise has also contributed to an Australian Institute of Occupational Hygienists (AIOH) working group aimed at defining

CYBERSECURITY UPLIFT PROGRAM

Within a continuously evolving technology and digital threat landscape ANSTO has embedded cyber security as a core investment stream within Information Technology. We will continue to assess our operating environment to determine the right balance of controls to protect and progress our organisation. ANSTO incorporates guidance and best practice from our industry

uplift program

Improvement in safety culture

Improvement in site-wide safety

what good worker health looks like and creating a framework of leading indicators to help employers demonstrate yearly progress. This approach will be championed more widely through representation at various national training events.

Manual handling and bodily stress remain as contributors to workforce injuries at ANSTO. Further work has been undertaken to assess and control these hazards and risks through the implementation of wearable sensor technology and the trial and use of exoskeleton - mechanical assistance devices.

partners, our regulators as well as the Australian Signals Directorate (ASD) including the Essential Eight and International Atomic Energy Agency. ANSTO is committed to maturing security information and event management, vulnerability management, and advancing its user awareness and training services.

Increase in opportunities for improvement (OFI) to actual incidents recorded*

Zero class 1 incidents

Year on year decrease in class 2 & 3 incidents**

* OFI – An event that did not result in any adverse effects to personnel or the environment and is not considered to have had the potential to cause a lost time injury, medical treatment injury or exposure of personnel, or harm to the environment; but could have resulted in a minor occurrence or damage to plant and equipment.

** Class 1 – Damage that permanently alters a person’s life; Class 2 – Damage that temporarily alters a person’s life; Class 3 – Inconveniences in person’s life or 1–5 days/shifts off work.

Our Traditional Custodians

ANSTO is proud to continue to build and strengthen our relationships with Aboriginal and Torres Strait Islander communities and other important stakeholders.

The basis of this is a respectful relationship with the local communities of Dharawal at Lucas Heights and the Boonwurrung and Woiwurrung of Kulin Nation at Clayton, where our two campuses are located. It extends to cultural representations at both sites in consultation with local groups and advisors. Local sponsorship activities include the provision of educational resources to local schools that highlight Aboriginal cultural values. Educational outreach also includes Aboriginal cultural content for students and teachers relating to how nuclear techniques are used to confirm the antiquity of Aboriginal culture.

As a national research organisation, ANSTO has research collaborations with academic partners and local Aboriginal and Torres Strait Islander communities in areas such as Kakadu and the Kimberley where connections to Country span thousands of years. Nuclear and accelerator techniques have provided novel approaches to the challenge of dating rock art and

Reconciliation Action Plan

evidence of occupation extending back 65,000 years or more. In a contemporary setting, ANSTO promotes the blend of traditional Indigenous knowledge and Western science to find sustainable solutions to environmental challenges. Aboriginal and Torres Strait Islander peoples’ understanding of the Australian environment is important to ANSTO, we recognise these peoples as Australia’s first scientists, navigators, mathematicians, and engineers. Their intrinsic understanding and scientific approach provide the potential to develop new sustainable solutions. It is important for people from all Aboriginal and Torres Strait Islander communities to be an integral part of the research activities ANSTO undertakes when on Country.

ANSTO has supported research on water resources for rural and remote communities and provenance work to support Indigenous business.

ANSTO demonstrates its commitment to Reconciliation through the implementation of our Reconciliation Action Plan (RAP), a meaningful, organic document that guides and informs our organisational governance and processes supporting Aboriginal and Torres Strait Islander peoples. ANSTO’s RAP is the blueprint for ANSTO to make progress in three key areas of Aboriginal reconciliation:

1. Relationships –Building and strengthening relationships with Aboriginal and Torres Strait Islander peoples.

2. Respect –Increasing understanding, value, and recognition of Aboriginal and Torres Strait Island culture, knowledge, histories, and achievements.

3. Opportunities –Improve employment outcomes and increase supplier diversity.

The RAP was developed by ANSTO’s RAP Working Mob, a committee that guides ANSTO on engagement and outreach with respect to Aboriginal and Torres Strait Islander peoples and communities. The framework, as developed by Reconciliation Australia, provides organisations with a structured approach to advance reconciliation. Each type of RAP is designed to suit an organisation at different stages of their reconciliation journey. ANSTO currently holds an ‘Innovate RAP’ and over the course of this Plan, we commit to embedding long-term reconciliation business strategies, to actively champion initiatives to empower Aboriginal and Torres Strait Islander peoples. ANSTO has made good progress in the area of Respect and is now focused on relationships with local groups, support for Indigenous businesses and workforce targets.

Reconciliation Action Plan Developing and strengthening relationships with Aboriginal and Torres Strait Islander peoples, engaging staff and stakeholders in reconciliation, and developing and piloting innovative strategies to empower Aboriginal and Torres Strait Islander peoples.

Our strategy in summary

Nuclear science and technology for the benefit of all Australians

OUR STRATEGIC OBJECTIVES

1. Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure

2. Improve the health of Australians by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases

MISSION

To deliver knowledge, value and trust through the application of nuclear science, technology and engineering

3. Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community

4. Lead the development of a nuclear capable workforce aligned with government policy objectives OUR VALUES

Our strategy and our priority activities

STRATEGIC OBJECTIVE 1 –

Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure

Operate world-class research infrastructure and leverage capabilities to deliver outcomes for Australia

Our infrastructure places Australia at the forefront of translational nuclear research and innovation for the benefit of public health, industry, and the environment. It is used by universities, researchers, and industry both from around Australia and internationally.

ANSTO’s national and landmark science and research infrastructure comprises

ANSTO’s research focus areas

OPAL multi-purpose reactor Australian Centre for Neutron Scattering Australian Synchrotron

Centre for Accelerator Science National Deuteration Facility

Key activities for 2024–2028:

How we will deliver on our strategy and purpose

OPAL multi-purpose nuclear reactor upgrades

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20-megawatt multi-purpose nuclear reactor that has been operating since 2007. OPAL is one of a small number of reactors worldwide with capability to support research in the fields of human health, the nuclear fuel cycle, and the environment. OPAL also contributes to the production of 80% of Australia’s nuclear medicine, neutrons for research at the Australian Centre for Neutron Scattering and processes over 50% of the world’s neutron transmutation doped silicon used by the global semi-conductor industry.

OPAL uses low enriched uranium fuel in a compact core which is cooled by light water and surrounded by a heavy water neutron moderator. It is also equipped with a Cold Neutron Source (CNS) operating at minus 250 degrees Celsius, which provides research capabilities in neutron scattering. This CNS has a defined operating life of 15 years and its planned upgrade commenced March 2024 and is expected to be completed by the end of September 2024. This upgrade will enhance our ability to provide scientific infrastructure for research and industry partners. The application of OPAL’s comprehensive asset management strategy has also enabled an upgrade of the reactor’s digital protection system. This system monitors critical reactor parameters and is a primary system required for reactor safety. This upgrade to the latest available technology will continue to support safety, provide reliability and ensure effective operational maintenance for the future.

ANSTO is preparing for a shipment in 2025 of spent fuel from the OPAL reactor to a reprocessing facility in France. This will be the second spent fuel shipment, the first of which was successfully carried out in 2018. Under agreement with France, spent fuel is sent to the La Hague facility where it is reprocessed – removing unused uranium and plutonium, and safely immobilising the residual waste in glass, in a process called vitrification.

ANSTO’s Australian Centre for Neutron Scattering (ACNS) upgrades

ACNS uses neutrons from the OPAL reactor to enable scientists and industry to solve complex questions and problems in areas of national importance, including health, food, materials, engineering, quantum materials, energy, cultural heritage and environmental science. In the past year, ACNS has celebrated a milestone of 2000 scientific journal articles. Enabling this research has been the continuous upgrading of critical instruments, including this year’s upgrade of Koala (Laue diffractometer) and transition to the user program. Completion of the Bilby (small angle neutron scattering) detector upgrade, which will ensure its reliability, scientific capabilities and performance, and future maintainability, was completed in early July 2024.

In FY25, ANSTO will continue to upgrade of critical instrument control systems at the ACNS. These investments will ensure ANSTO’s neutron scattering research infrastructure remains world-class and can operate reliably for decades to come.

These investments will include:

. Replacement of critical instrument control systems and equipment,

. Wombat (diffractometer) instrument detector replacement. The new detector will be more reliable, scientifically capable, have better performance, and be easier to maintain.

Project BRIGHT

The Australian Synchrotron, ANSTO’s research facility located at our campus in Victoria, utilises accelerator technology to produce powerful beams of light, up to a million times brighter than the light from the sun. Synchrotron light is guided into the beamlines that are used for a wide variety of research purposes, including in the fields of human health, energy, environmental science, agriculture, and manufacturing. The unique properties of synchrotron light provide researchers and industry with results that are greater in accuracy, clarity, and timeliness than those that could be obtained using conventional laboratory equipment.

Since 2018, ANSTO has been undertaking the BRIGHT Beamline Program to design, construct, and commission eight new beamlines at the Australian Synchrotron. To date, $105 million has been secured for the BRIGHT Beamline Program from 33 universities, research institutes, and government agencies in Australia and New Zealand. The creation of these new beamlines will nearly double the Synchrotron’s research capacity, specifically to address complex issues like climate change, development of new energy technologies, food science, and disease detection and treatment. This level of support highlights the importance of ANSTO’s Australian Synchrotron and these new capabilities to the Australian and New Zealand innovation and science ecosystem.

These beamlines will significantly improve ANSTO’s nuclear research capabilities. For example, the Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) currently under construction are set to improve materials science and manufacturing research, such as characterisation of structure-function relationships in component materials of energy storage, production, and conversion systems –batteries, fuel cells, thermoelectric materials, among others.

During the past 12 months, the BRIGHT Beamline Program has achieved a number of significant milestones:

. Construction of the Nanoprobe Satellite Building and the beam transfer tunnel for the 100 m long X-ray Fluorescence Nanoprobe beamline.

. Installation of the wiggler insertion device and photon delivery system for the Advanced Diffraction & Scattering beamlines.

. “First light” achieved on the High-Performance Macromolecular Crystallography beamline, allowing the commencement of hot commissioning.

. First User experiments on the Biological Small Angle X-ray Scattering beamline in fields of nanoscience, pharmaceutical formulations, and structural biology.

. First scientific results published from the Microcomputed Tomography, and Medium Energy X-ray Absorption Spectroscopy beamlines in the fields of catalysts and energy materials, environmental science, and advanced electronics.

The new BRIGHT beamlines include:

Microcomputed Tomography beamline (MCT)

2x Medium Energy X-ray Absorption Spectroscopy beamlines (MEX 1&2)

Small Angle X-ray Scattering beamline (BioSAXS)

2x Advanced Diffraction and Scattering beamlines (ADS 1&2)

Nanoprobe beamline (NANO)

High Performance Macromolecular Crystallography beamline (MX3)

UNDER CONSTRUCTION

UNDER CONSTRUCTION

UNDER CONSTRUCTION

ANSTO’s Centre for Accelerator Science (CAS) upgrades

CAS operates four mega-electron volt ion accelerators, a suite of 12 laboratories and electrical and mechanical support facilities to underpin research and innovation communities with accelerator science applications in materials characterisation, analysis, modification and testing. ANSTO’s ion accelerators support research and industry user communities to explore the past, understand the present, and design for the future with a suite of capabilities that can help answer some of the most complex and exciting questions of today. In FY25, ANSTO will continue to upgrade critical accelerator systems and equipment on the STAR and ANTARES accelerators. This is funded through the 2020 Research Infrastructure Investment Plan, which is part of The National Collaborative Research Infrastructure Strategy (NCRIS).

CAS will also initiate the design phase of a program of step-change uplift accelerator mass spectrometry sample preparation facilities, ion beam irradiation analysis capabilities and ion beam irradiation beamlines and target chambers. This program of uplift is supported with funding secured through the 2023 NCRIS Research Infrastructure Investment Plan. These investments will ensure:

. Longevity and efficient operation of world-class accelerator science capabilities and instrumentation delivered by CAS.

. Increased automation.

. Increased quality and quantity of user interactions.

. Industry engagement through a linked innovation and translation activity.

ANSTO’s

National Deuteration Facility (NDF) capability expansion

Deuterium isotope labelling of molecules enables scientists to investigate structures and functions of molecules and how they interact with each other in complex biological and chemical systems. The National Deuteration Facility offers many labelling techniques for the benefit of a wide range of science applications, from drug discovery to advanced manufacturing for Australia and the world. This unique facility is the only one of its type in the Southern Hemisphere and one of a few in the world.

Our work is critical in providing onshore support to drug discovery programs in Australia, and reducing the inherent risks of dependency on outsourcing deuterium labelling work for molecular characterisation and bioanalysis to overseas countries. This implies that drug discovery programs in Australia can utilise the NDF capabilities in deuterium labelling, reducing their reliance on international commercial suppliers and bioanalysis service providers with the associated challenges in delivery time frames and logistics.

In FY24, NCRIS funded two step-change activities in the NDF to allow enhanced productivity and wider capability for the provision of deuterated molecules.

These activities are:

1) Deuteration for applications beyond neutrons to include Nuclear magnetic resonance (NMR), Infrared (IR), Mass spectrometry (MS) and other spectroscopic techniques; and

2) Deuteration and stable isotope labelling using synthetic biology platform.

Benefits of the expansion include:

. Increased production capacity of deuterated lipids and their building blocks by up-scaling reactions using new hydrogen/ deuterium (H/D) exchange techniques based on flow chemistry systems.

. Provision of stable isotope internal standards for drug discovery and analysis programs in Australia.

. Developing a new stable isotope labelling platform based on synthetic biology to expand the applications and diversity of the labelled molecules.

. Building Australia’s human capital in deuteration by attracting and retaining researchers of high international standing and by providing high-quality postgraduate and postdoctoral training for the next generation of researchers in deuteration.

OPAL multi-purpose reactor upgrades

Replacement of CNS

Replacement and expansion of neutron beams

Project BRIGHT

MCT, MEX1&2

BioSAXS, MX3

2

ACNS upgrades

Research Infrastructure Investment Plan

Wombat Detector Upgrades

Bilby Detector Upgrades

CAS upgrades

Research Infrastructure Investment Plan

Automation of sample processing and end station mounting

CAS expansion scoping studies

NDF capability expansion

Provide new techniques for deuteration of molecules (Flow Chemistry)

Provide stable isotope internal standards to industry

Provide Synthetic Biology capability for labelling of molecules

Build Australia’s human capital in deuteration

Ensure the ongoing and safe operation of the OPAL nuclear reactor and optimally position ANSTO to supply radioisotopes reliably, undertake effective silicon irradiations, and deliver neutrons for research and industry applications.

Expand the existing infrastructure at the Australian Synchrotron, making it the ‘go to’ facility for the nation’s scientific imaging capabilities for addressing national and global challenges.

Ensure ANSTO’s state-of-the-art neutron scattering research infrastructure remains world-class and can operate reliably for decades to come.

Ensure longevity and efficient operation of the world-class capabilities and instrumentation delivered by CAS, and provide sovereign capability for ion beam precision irradiation to meet the national need for facilities supporting space, defence and advanced manufacturing.

Expand existing capabilities to transition NDF from primary support of characterisation techniques to enabling research utilising deuterated molecules as functional materials in industry and biotechnology programs.

P Preparation I Implementation C Completion M Monitoring and improving

OPAL (Days at power)

ANSTO Australian Synchrotron (% utilisation)

ANSTO Australian Centre for Neutron Scattering (% utilisation)

ANSTO Centre for Accelerator Science (% utilisation)

ANSTO National Deuteration Facility (% utilisation)

OPAL will continue its strong record of performance, retaining its status as one of the most reliable multi-purpose reactors in the world.

The Australian Synchrotron is one of the leading synchrotron facilities of its kind, maximising utilisation to deliver beneficial research outcomes for Australia. ANSTO measures the Australian Synchrotron’s performance by percentage availability. This is the delivered number of hours available out of the scheduled number of hours available.

ACNS will remain a world-leading facility, capitalising on the high availability of the OPAL reactor to support Australian researchers and industries. ANSTO measures the performance within ACNS by percentage utilisation. This is the number of actual operating days out of the scheduled operating time.

CAS will maximise utilisation of the available capacity of Australia’s accelerator technologies and expertise. ANSTO measures the performance within CAS by percentage utilisation. This is the number of actual operating days out of the scheduled operating time.

NDF will maintain a world-leading position in the provision of a wide variety of complex deuterated chemicals for research that are not readily available anywhere else. ANSTO measures the performance within NDF by percentage utilisation. This is the percentage of the NDF production capacity utilised by the approved user demand.

* The decreased days at power of OPAL in 2026-27 is due to a planned extended shutdown to replace the inventory of heavy water. This replacement is estimated to require a 6 week shutdown.

** The decreased % utilisation of the NDF in 2024-25 is due to power, remediation, and construction disruption from the neighbouring Nuclear Medicine Manufacturing Facility construction

*** User Satisfaction (NPS) is measured through a voluntary survey.

Note: % utilisation performance measures are calculated as utilisation divided by availability and represented as a percentage.

Collaborate, deliver, and translate research that has scientific and industrial impact

for Australia and the world

ANSTO uses nuclear science and technology to deliver real-world benefits to Australia through excellence in research, supporting access to nuclear technologies to address national priorities, informing policy and boosting industry engagement. Research impacts are delivered in four key areas:

Environment – where our ability to measure isotopes in the field informs climate change management and provides the tools to help administer Australia’s groundwater resources.

Nuclear technologies – where our materials and modelling science informs better use of Australia’s OPAL research reactor and is driving the development of Australia’s world-leading Synroc® nuclear waste management technology, designed to reduce lifecycle costs, disposal volume, and the environmental risk of nuclear waste.

Key activities for 2024–2028: How we will deliver on our strategy and purpose

Updated ANSTO research and development strategy and implementation

ANSTO is furthering the delivery of nuclear science and technology research and development in the Nation’s interest.

Real world impact is something we take seriously at ANSTO by aligning our work to Australia’s national science and research priorities, improving human health, saving lives, supporting Australian industries, and protecting the environment.

We are focussed on fundamental research, developing intellectual property, promoting commercialisation and positively supporting partners to migrate through the technology readiness levels (TRL).

ANSTO provides access to its substantial research infrastructure at Lucas Heights NSW and Clayton Victoria for an international user community.

Health – where our unique ability to make radioisotopes and understand radiobiology allows us to improve diagnostics and treatment of disease.

Use of nuclear science and technology infrastructure for public benefit – ANSTO administers Australia’s most significant suite of nuclear research infrastructure and has delivered benefits including the development of life saving drugs now on the pharmaceutical benefits register, building better batteries, improving polymer manufacture, and testing for contaminants such as PFAS (per- and polyfluoroalkyl substances), the so-called ‘forever chemicals’ which are now ubiquitous in food packaging, cleaning and personnel care products and in many materials which are resistant to water, grease and mechanical erosion.

Current Research Information System and Portal (CRISP) project

The CRISP initiative aims to equip our organisation with cutting-edge software tools and analytics, enhancing our ability to manage information and data across all research endeavours. Through this project, we anticipate enhanced reporting, analytics, and compliance support. Building upon the scoping study conducted in FY22, ANSTO is currently rolling out the Research Infrastructure Management System (RIMS), which is slated for completion by the end of the fiscal year 2024-25. We have completed the requirements for the Research Portal, which will serve as the primary platform for research proposal submissions across ANSTO’s infrastructure users. Additionally, the high-level requirements have been gathered for a Laboratory Information Management System (LIMS).

Updated ANSTO research and development strategy and implementation

CRISP project

Research Information Management System (RIMS)

Laboratory Information Management System (LIMS)

Improved health outcomes for all Australians through the effective application of radioisotopes and radioisotope-enabled technologies, including radiopharmaceuticals.

Publications undertaken with national and international collaborators

* ANSTO only or acknowledgement of ANSTO ** Excluding National Collaborative Research Infrastructure Strategy (NCRIS) grants.

3.1.3

Build new knowledge, drive innovation, and support training and development for the safe management of radioactive waste

Through utilisation of the OPAL multi-purpose nuclear reactor to produce nuclear medicines, scientific research, and industrial applications, ANSTO generates different kinds of radioactive waste, including spent fuel from the OPAL reactor and waste associated with the production of nuclear medicine. ANSTO has over 70 years of experience in advancing the management, research, and development of spent nuclear fuel to deliver safe and stable forms of radioactive waste.

Key activities for 2024–2028: How we will deliver on our strategy and purpose

Develop and implement world-leading innovative radioactive waste treatment and management technologies

Innovative and sustainable waste conditioning and treatment technologies, such as ANSTO Synroc®, will bring benefits to both domestic and international holders of radioactive waste. Such developments support ANSTO’s core capability and legislated mandate to temporarily store and manage radioactive waste it produces.

The Synroc® waste treatment technology is an Australian innovation that mimics naturally occurring geological processes to transform nuclear wastes into a stable solid phase formed by using high temperature and pressure processes. The final waste product produced is in a form that is ready for disposal. The world-first Synroc® Waste Treatment Plant is currently transitioning between fit-out stage and commissioning of process plant. The new plant will treat liquid waste by-products from the manufacture of Mo-99.

Implement intermediate-level waste (ILW) storage solutions

Through the use of ANSTO’s research infrastructure, and the production of radiopharmaceuticals for both Australian and international communities, ANSTO generates different kinds of radioactive waste, which is safely managed on-site. On average, between 2018-23, ANSTO generated 66 cubic metres of low-level solid waste (LLSW, also known as contact-handled solid waste) annually, and 10 cubic metres of intermediate-level solid waste (ILSW, also known as remote-handled solid waste). ANSTO also currently stores over 1,200 cubic metres of ILSW from legacy activities.

Legacy acidic liquid waste from past Mo-99 production processes is currently stored in shielded tanks that have been in service for almost 50 years. An expansion of storage capacity for intermediate level waste is currently underway, this will accommodate intermediate solid and liquid waste and ensure that ANSTO can safely manage this waste, pending the establishment of a national radioactive waste facility.

Develop and implement world-leading, innovative radioactive waste treatment and management technologies

Implement ILW storage solutions

Construction of new storage facility for intermediate level solid and liquid waste

Construction and operation of a world-first Synroc® Waste Treatment Plant to ensure liquid waste by-products from the manufacture of Mo-99 are treated in a safe, economical, and sustainable way.

Ensure

Key activities for 2024–2028: How we will deliver on our strategy and purpose 3.1.4

the reliable and sustainable supply of commercial products and services for the benefit of Australia and the world

Critical and strategic minerals

With an abundant resource endowment and strong regulatory and compliance environments, Australia is ideally positioned to supply critical and strategic minerals to the world.

Critical and strategic minerals support a range of sectors including electronics, defence, space, and medicine. Many are also fundamental to the technologies required for transition to net zero carbon emissions. These minerals have been identified as a strategic resource, with priority given to them by Australian Government policy initiatives such as the Australian Critical Minerals Research and Development Hub (R&D Hub).

ANSTO is contributing to the development of sustainable alternative supply chains and building sovereign capability for Australia’s critical minerals industry through the Australian Critical Minerals R&D Hub – an interagency partnership between ANSTO, CSIRO, and Geoscience Australia, along with the Critical Minerals Office within the Department of Industry, Science and Resources (DISR). As part of its role in the Hub, ANSTO is leading and contributing to programs concerned with critical and strategic minerals such as high purity quartz (essential for solar panel production), rare earth elements (essential for high strength magnets in wind turbines), gallium (essential for semi-conductors and other electronic applications) and tungsten (essential for tooling and advanced manufacturing).

The ANSTO Minerals team has been a prominent and trusted technology developer and technology provider to the Australian mining and minerals processing industry for more than 40 years, and our reputation and influence is global, especially in critical and strategic minerals processing. We are committed to providing practical solutions and developing innovative technologies which are focused on the future needs of our clients.

Silicon irradiation –neutron transmutation doped (NTD) silicon

Silicon irradiation also known as Neutron Transmutation Doping (NTD), is conducted in the OPAL reactor. The NTD process is used when a high level of precision and uniformity in dopant (phosphorous) distribution is required for the irradiated silicon. Through this process thermal neutrons react with the silicon atoms, changing some of the silicon atoms into phosphorus atoms, which reduces the resistivity of the silicon crystal and improves its ability to conduct electricity. Customers deliver silicon ingots to ANSTO which are then irradiated in OPAL and are returned to customers for use.

High quality NDT silicon is particularly desirable for solid state switching devices used in high voltage and high-powered applications such as power infrastructure, high-speed rail, industrial automation, and the international electric vehicle and hybrid electric vehicle automotive industry. High quality NDT silicon is also critical for the progression towards net zero carbon emissions since it is essential for efficient power transmission, reliable grids, and the ability to connect renewable energy sources.

Reliable and sustainable supply of commercial products and services for the benefit of Australia and the world.

* Delivery in full and on time.

Note: DIFOT is calculated as delivery ‘in full’, irradiated within a specified target resistivity tolerance and proportion of material without physical defect or damage and ‘on time’, is the dispatch from ANSTO on or before an agreed date.

Key activities for 2024–2028: How we will deliver on our strategy and purpose 3.1.5

Ensure ANSTO operates sustainably

We will continue to ensure the sustainability of our operations by:

Reducing our environmental footprint.

Maintaining and upgrading our infrastructure and sites to secure the continuity of activities.

Campus Renewal Plan 2035

ANSTO is implementing a multi-year plan to re-develop ageing infrastructure at the Lucas Heights campus over the period to 2035. This will enable more efficient use of the site, more energy efficient buildings and enhance the environmental sustainability of the site overall. The most recent example of this is the installation of over 3,200 solar panels across the rooftops of the Australian Synchrotron, reducing its carbon footprint by over 1,680 tonnes of CO2 per year.

This renewal plan will also provide improved facilities for research and other activities and create opportunities for organisations which are aligned to ANSTO’s strategy to co-locate. The most significant project currently underway is the replacement Nuclear Medicine Manufacturing Facility (NMMF). Highlights for the Campus Renewal Project’s progress going forward include:

. Enabling site works for the NMMF project; including utilities upgrades, decommissioning, and demolition of redundant buildings, and temporary accommodation for staff while the project is underway.

. Scoping and planning underway for other site supporting assets, such as improving electrical network resilience.

. New intermediate waste storage facility concept design and delivery planning (ILWCI).

. Site buildings utilisation analysis and concept designs have been completed to inform the planning for replacement office and laboratory building in a further phase of the Campus Renewal Program.

Developing an environmental sustainability roadmap

ANSTO continues to implement its Environmental Sustainability Strategy. The strategy and the actions to achieve it are regularly updated in response to government policy changes, emerging environmental issues, and organisational priorities. ANSTO has also prepared an emissions reduction plan to achieve net zero scope 1 and 2 emissions by 2030, aligning with the Australian Government Net Zero in Government Operations Strategy.

Campus Renewal Plan 2035

Developing an environmental sustainability strategy

Plans in place for the future of our Lucas Heights campus.

Put plans in place to reduce our environmental footprint and contribute to a more sustainable Australia.

P Preparation I Implementation C Completion M Monitoring and improving

STRATEGIC OBJECTIVE 2 –

Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases

Ensure the reliable and sustainable supply of nuclear medicines, products and services

Through targeted investment in manufacturing, research, and development capabilities, ANSTO maintains its focus on the reliable supply of nuclear medicines that will improve health outcomes for Australia. Australia is one of the few nations in the world to produce radioisotopes necessary for nuclear medicine procedures. It produces approximately 80 per cent of nuclear medicine isotopes used nationally.

Key activities for 2024–2028: How we will deliver on our strategy and purpose

Nuclear Medicine Manufacturing Facility (NMMF)

In the 2023-24 Budget, and following the September 2023 Minister’s announcement, the Commonwealth Government confirmed funding to construct a new Nuclear Medicine Manufacturing Facility and to secure a reliable and sovereign nuclear medicine supply chain. ANSTO’s current Nuclear Medicine Production Facility is over 60 years old, and its replacement is critical to maintain and sustain the supply of life-saving medicine for all of Australia. The new facility is designed to achieve the following goals:

. Meet domestic demand for technetium, lutetium, and iodine (the core products) and provide the flexibility to respond to market and technological changes related to the production of other nuclear medicines.

. Deliver a more reliable supply of reactor-based radioisotopes for Australia. This includes being able to produce nuclear medicines to ensure sovereign control over the supply of these critical diagnostic and therapeutic agents.

. Support academic and private sector medical researchers, by providing an accessible centre of expertise and contract manufacturing areas for the development of emerging nuclear medicine products.

In the 2023-24 period, this project saw rapid progress: the establishment of a strong governance framework through the ANSTO NMMF Steering Committee; publication of a request for tender via Austender; engagement with critical European and North American suppliers of hot-cells (a major complex component of the production lines for nuclear medicine products with long supplier lead times); referral to the Department of Climate Change, Energy, the Environment and Water (DCCEEW) under the Environment Protection and Biodiversity Conservation Act 1999 ; and hosting of a Public Works Committee inspection and public hearing. The Public Works Committee findings were recognised by the House of Representatives motion that ‘it is expedient to carry out’ the NMMF project. The next major milestones for the 2024-25 period include securing a Principal Consultant to further advance the design of the facility, and referring a siting license submission to the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA).

The construction of this facility is critical to securing the future production of life-saving nuclear medicine for Australia.

Ongoing maintenance of our Nuclear Medicine Production Facility

In order to provide a safe, secure, and sustainable supply of nuclear medicines from the current facility, pending the operation of the new facility a significant redesign of maintenance strategies and capital improvement plans is required. An assessment of the facility and its systems is being undertaken to determine the most appropriate maintenance strategy.

The current Asset Management Plan includes a capital improvement plan that initially focuses on the remediation of the facility over the next five years to enable it to continue to run safely and reliably. Work will then transition to an end of useful life maintenance plan.

Five-year research and development strategy for successful innovation in health

Plans are being implemented to develop a pipeline of nuclear medicine products and technologies to address areas of unmet clinical need. A key initiative is to develop and evaluate new radioisotopes and radiopharmaceuticals for disease diagnosis and therapy. World class radiochemistry capability is being developed to enable innovation in radioisotope separations, radiolabelling, production scale-up and advanced manufacturing. Initial priority is being given to a program for production of terbium-161 by irradiating gadolinium-160 in OPAL. In FY25-28, the 5-year strategy plans to contribute to the new Nuclear Medicine Manufacturing Facility; through supporting the design of the facility and leading technology demonstration activities for Lu-177, a Tc-99m generator, and I-131 products.

New Nuclear Medicine Facility Safe, quality and reliable delivery of nuclear medicines for Australia.

Ongoing maintenance of our Nuclear Medicine Production Facility

Five-year research and development strategy for successful innovation in health

Sustainment of operations within the Nuclear Medicine Production Facility.

Improved health outcomes for all Australians through the effective application of radioisotopes and radioisotope-enabled technologies including radiopharmaceuticals. I I I I P Preparation I Implementation C Completion M Monitoring and improving

* Delivery in full and on time.

Note: DIFOT is calculated as delivery in full of the product along with delivery on time.

STRATEGIC OBJECTIVE 3 –

Australia’s source of nuclear expertise, advice and services to governments, academia, industry and community

Deliver expert advice to local, state and federal governments, and other stakeholders to support the national interest

ANSTO is a science, research and engineering partner, that collaborates and shares information with universities, industry, other publicly funded research agencies, research institutes, cooperative research centres, Australia’s Chief Scientist and international partners. ANSTO advises Government on nuclear science and technology. ANSTO works closely with the Office of the Honourable Ed Husic, MP, Minister for Industry and Science, the Department of Industry, Science and Resources, along with other Commonwealth agencies, including; the Department of Foreign Affairs and Trade, Department of Defence, Department of Health and Aged Care, Department of the Prime Minister and Cabinet and the Australian Radioactive Waste Agency.

Key activities for 2024–2028:

our strategy and purpose

Nuclear Security Science Capability (NSSC) –planning and design

The NSSC Program is progressing to the design development phase as part of the preparation of its detailed business case. Following project establishment and recruitment, the ANSTO Program team has initiated strategies and plans including the implementation of international working groups with the US and UK to learn from other nuclear industry experts. In parallel, several specialist consultants have recently been retained to enable the delivery of a Detailed Business Case to Government for consideration.

Subject to Government approval, the Program would move into further planning, detailed design, and construction of a new facility at ANSTO’s Lucas Heights campus, housing multiple nuclear security and science capabilities which would be operational by the early 2030s.

Nuclear-powered Submarines (NPS Program)

On 14 March 2023, Prime Minister Albanese, US President Biden, and Prime Minister Sunak of the United Kingdom, announced a pathway for Australia to acquire a conventionally armed, nuclear-powered submarine capability. This is a multi-decadal, whole-of-nation effort. Reflecting our position as the national nuclear science centre-of-excellence, ANSTO has been providing support and advice to the Australian Submarine Agency (ASA) and other Government organisations. In FY24, ANSTO increased its training and educational offerings for the NPS program, including 8 Basic Literacy courses with a total of 166 participants and 2 Senior Officer courses with a total of 15 participants.

The support ANSTO is providing to the ASA includes:

. Dedicated and specialist technical advice on a range of issues including:

» safe, secure, and effective operation of nuclear facilities

» nuclear science and technologies as applied to nuclear-powered submarines

» specialised training and development

» development of a nuclear-capable workforce including through professional placements

» public communications, and development of social licence.

. Support under the Visiting Ships Panel (Nuclear) (VSP(N)) for increased radiological monitoring and training necessitated by increased visiting of nuclear-powered submarines.

. Increased regulatory oversight on ANSTO arising from the NPS program

. Radiological monitoring expertise to help characterise Defence sites and conduct other environmental analysis.

Nuclear Security Science capability –planning and design Planning, design and preparation of a Detailed Business Case for an enduring nuclear security science capability. P I I I

Nuclear-powered submarines Support government to implement the AUKUS Nuclear Powered Submarine Pathway. I

P Preparation I Implementation C Completion M Monitoring and improving

* 2025-26, 2026-27, and 2027-28 implementation status is subject to Government decision.

of Nuclear-Powered Submarine visits supported*

of Defence RFIs Responded to in Agreed Time**

* 2025-26, 2026-27, and 2027-28 status is subject to Government decision.

** 2025-26, 2026-27, and 2027-28 status is subject to Government decision.

3.3.2

Participate in global and regional nuclear discussions and fora to ensure that Australia remains a leader in the application

of nuclear science and technology

As Australia’s primary nuclear organisation, ANSTO is at the forefront of international leadership in nuclear forums. We are delivering on Australia’s commitment to share the peaceful uses of nuclear science and technology with the world. We do this through our engagement in the International Atomic Energy Agency (IAEA), the Regional Cooperative Agreement for Research, Development and Training related to Nuclear Science and Technology in Asia and the Pacific (RCA for Asia and Pacific), the Forum for Nuclear Cooperation in Asia, the Organisation for Economic Cooperation and Development Nuclear Energy Agency, the Generation IV International Forum, as well as many other regional discussion fora and bilateral arrangements.

Measuring performance:

Facilitation of Australian participation and leadership in IAEA and RCA programs

Key activities for 2024–2028: How we will deliver on our strategy and purpose

Leadership in setting global nuclear standards

ANSTO will be among the leaders in setting global standards in the nuclear field. We will continue to influence the practice and evolution of standards in areas such as nuclear security, radiation safety and protection, decommissioning, nuclear forensics, management of research reactors, nuclear medicine production, research and analysis, and nuclear science education and outreach through our active and transparent participation in IAEA committees, working groups and expert missions across the world. We demonstrate our capabilities through being an IAEA Collaborating Centre, and support capability developing in our region through our membership of the Network of Analytical Laboratories, Asian Network of Educators in Nuclear Technology and the Analytical Laboratories for the Measurement of Environmental Radioactivity.

We will take strong positions in the OECD’s Nuclear Energy Agency (NEA) on gender balance, and also stakeholder engagement, trust, transparency and social sciences to ensure global norms continue to head in the right direction.

RCA: Participation in 80 per cent of active projects, leading ≥1 project

IAEA CRP: Participate in ≥10 projects relevant to nuclear applications

Leading impactful social and economic development in our region

ANSTO has concluded its role as Chair of the Regional Cooperative Agreement (RCA) which is an agreement between 22 countries under the auspices of the International Atomic Energy Agency (IAEA) Technical Cooperation Program. This treaty is the primary mechanism by which Australia demonstrates its support for the application of nuclear science and technology to bring socio-economic benefits to the Indo-Pacific region.

Following the conclusion of its role as Chair, Australia will maintain its membership of the RCA-AP Committee of Chairs until May 2025, where we will play a pivotal role in setting a regional development program that delivers on improving cancer care and food security in the Asia and Pacific region. We will also continue to be a valued partner of the IAEA Sub-Regional Approach to the Pacific, focusing on water management through isotope hydrology, nuclear science and communications outreach, and responding to the emerging needs of the Pacific. We will lead a project to combat food fraud in Asia to increase the value of regional trade for locally produced products important to the region, such as seafood.

Grow a more informed generation of Australians who understand the benefits of nuclear science and technology

Measuring performance:

Offer a range of resources for teachers and students to support the national science curriculum outcomes for years 3 to 12

Increase accessibility of STEM teacher training programs

Conduct educational tours and science experiences at ANSTO’s Lucas Heights and Clayton Campuses (visitors to ANSTO’s campuses per annum)

Deliver ≥ six national programs per annum

Deliver teacher professional development days in all states and territories

STRATEGIC OBJECTIVE 4 –

Lead the development of a nuclear-capable workforce aligned with government policy objectives

The demand for nuclear science and technology capabilities is at an all-time high and it is essential that we build a sustainable highly skilled STEM workforce, focussed on nuclear science and technology over the coming decade. This demand requires collaboration between industry stakeholders at all levels to grow nuclear-capable skills in the workforce of the future.

An expansion of Australia’s nuclear capability involves not only the recruitment of individuals with nuclear engineering and science qualifications, but also a range of other professional, semi-professional and trade qualified professionals with the specialist knowledge and training needed to work in a nuclear environment.

We employ some of Australia’s most talented people and we are committed to partnering with other organisations in government, industry, and education institutions to develop the next generation of specialised nuclear talent by:

Building upon ANSTO’s existing workforce talents and cross-skilling with industry to develop the specialist nuclear skills and experiences needed for an expanded capability pathway.

Leveraging extensive education and university linkages to support the education sector in strengthening nuclear curriculum.

Establishing robust succession planning tools and techniques that minimise the risks to ANSTO associated with the loss of critical skills and experience.

Servicing the training requirements of the external nuclear community through ANSTO’s deep nuclear technical training expertise and programs.

Providing mid-career collaborations and secondments with other nuclear agencies, both locally and internationally, to enrich career development pathways.

Focusing on the early career pipeline by building on the existing ANSTO programs and planning for increased positions and funding to prepare for future needs.

Leveraging and contributing to greater nuclear workforce planning initiatives with the Federal government.

Encouraging collaborations with other agencies on hosting early and mid-career placements and rotations.

Develop a workforce plan for the next generation of specialised nuclear professionals

Our people are amongst the nation’s most talented researchers, scientists, engineers, and nuclear experts. To protect Australia’s nuclear science and accelerator expertise, it is critical that we collaborate with other organisations in government, industry, and the education sector to develop the next generation of talent.

Key activities for 2024–2028: How we will deliver on our strategy and purpose

Organisation capability development

Considering key drivers to support the development of a sustainable nuclear workforce, the ANSTO early career program continues to expand and evolve. This includes the establishment of the Cadetship program as an additional pathway, the expansion of the intake of the Graduate program from 10 to 15 people and partnerships with other nuclear agencies to support graduate rotations across the nuclear sector. In addition, collaborations with universities to support the growth of the future STEM workforce, participation in such programs, development of nuclear curriculum and hosting of students to create a viable nuclear workforce will be undertaken.

The sustainability of nuclear-based knowledge is critical to ensuring security, safety, and innovation particularly related to defence, human health, food, agriculture, water, and energy. There are global concerns regarding the sustainability of nuclear-based knowledge due to a majority of the nuclear workforce approaching retirement leading to a loss of experience and knowledge. The Australian nuclear industry is facing labour difficulties with technical and highly specialised people being sought within the different nuclear agencies in Australia. Additionally, the broader Australian labour market has seen the lowest unemployment levels for many years.

ANSTO is proactive in continuous skill building and has a suite of programs to develop the talent pipeline across the organisation. We work with a range of educational institutions to create more career pathways in the nuclear workforce at all levels of industry.

These programs include:

Strategic Workforce Plan

In FY25, ANSTO is developing a strategic workforce plan with a five-year horizon to address the ways in which demand for workforce skills may change over the period. The workforce plan will be fully integrated with the annual business planning cycle.

Provide an inclusive environment that empowers our people and supports a culture of collaboration and engagement

ANSTO is committed to building a diverse and inclusive workplace that is equitable, where people can come to work and belong every day. A refreshed Diversity, Equity, Inclusion and Belonging Program and Calendar has been adopted that focuses on core pillars and programs of work across Employee Networks (LGBTQI+, Ignite Early Careers, Neurodiversity, Disability), significant calendar events (International Women’s Day, National Reconciliation Week, R U OK, Wear It Purple), Women (Women in Leadership and STEM, Workplace Gender Equality Agency Reporting) and the Reconciliation Action Plan. In addition, other initiatives in progress include a mandatory Respectful Workplace Program, Psychosocial Change Program, Annual Employee Experience Survey, Workplace Flexibility, Early Careers Programs (cadets and graduates) and Leadership Development Programs for all leader levels (Executive, Directors and General Managers, Middle and Frontline Management Fundamentals).

ANSTO extends its commitment to inclusiveness through its role in national and international partnership and nuclear governance roles, where it makes a noted contribution to gender equity.

Measuring performance and targets:

Psychological safety culture program

Psychosocial safety and well being are key priorities for ANSTO. Through dedicated support has seen positive shifts in psychological health and wellbeing and the organisations safety culture. We have incepted new technology and business processes to establish an improved monitoring capacity. These tools also allow for an analysis of behavioural change with respect to the reporting of psychosocial matters within a prevention and early intervention model. Over 300 leaders have attended skills training in creating a psychologically safe working environment, and all employees have access to a range of psychosocial educational materials and training modules. The broader program is now focussed on building maturity over time and will move into further tranches of work, most notably the activation of a Psychosocial Early Intervention Working Group to monitor the health and wellbeing of employees through integrated reporting, an organisation wide Psychosocial Hazards Risk Assessment to better understand the hazards and risk footprint and ongoing capability and skills training for Officers, leaders, employees and enabling functions and roles over the next 2 years.

Our operating environment

Ministerial expectations

ANSTO is an agency within the Industry, Science and Research portfolio. The Minister responsible for ANSTO is the Hon Ed Husic MP, Minister for Industry and Science. On 9 December 2022, the Hon Ed Husic MP, Minister for Industry and Science, issued ANSTO with a Statement of Expectations This Statement outlines the Australian Government’s expectations of ANSTO including important contributions that ANSTO can make to national priorities and supporting the health of Australians through nuclear medicine production. The Government’s national policy priorities include advancing First Nations science, achieving net zero emissions, delivering a Future Made in Australia, supporting the health of Australians, and managing research infrastructure.

ANSTO is committed to ensuring that its strategy is fully aligned with the Statement of Expectations. ANSTO’s Statement of Intent published on 15 June 2023 outlines the response to the Statement of Expectations, and how ANSTO will continue to work in close partnership with the Minister for Industry and Science, the Department of Industry, Science and Resources (DISR), other Commonwealth agencies, universities, other research institutions and industry.

Building communities/community engagement

ANSTO’s Lucas Heights campus is located within the Sutherland Shire and is one of the area’s major employers and economic hubs. Over one-third of ANSTO’s workforce resides in the Sutherland Shire. Approximately 200 staff are employed at ANSTO’s Clayton campus, home to the Australian Synchrotron. Community engagement is a strong priority at ANSTO through STEM education with local schools and site visits and event sponsorship with local business groups and community groups.

Through our various education and outreach programs, we facilitate knowledge sharing to connect ANSTO’s science and research with Australia. ANSTO will continue to seek further opportunities to engage with our local communities. ANSTO has undertaken a second Reconciliation Action Plan (RAP) as part of our commitment to the goals of reconciliation. Through our RAP, ANSTO will conduct and support research to achieve synergies between traditional Aboriginal knowledge and current scientific and technological practice.

Nuclear Energy

As a government science organisation, ANSTO takes an impartial position on nuclear energy. The debate around nuclear energy is a matter for Government and public policy. Under our mandate, ANSTO is committed to providing expert technical advice to the Australian Government on all matters relating to nuclear science and technology, as required. This is underpinned by our strong expertise in nuclear science, research, and technology over our extensive history. We do this with complete neutrality and continue to provide our expertise in science across climate, materials, and the environment to support Australia’s commitment to net zero.

Consistent with our statutory functions, we regularly observe and track developments and participate in research into nuclear technologies around the world. ANSTO publishes information on our website to keep the Australian public informed of very topical global developments happening with nuclear technologies. We do this by drawing from reputable sources such as academic papers and reports from agencies such as the International Atomic Energy Agency (IAEA), OECD’s Nuclear Energy Agency (NEA) and the Australian Energy Market Operator (AEMO).

The Hon Ed Husic MP

Radioactive waste management

Australia is committed to providing safe and sustainable radioactive waste management over generations. Radioactive waste is currently managed at around 100 locations around Australia including hospitals, industrial sites, mines, and at ANSTO. All radioactive waste in Australia is managed in accordance with national and international standards. The management of waste generated by Commonwealth bodies, including ANSTO, is regulated by an independent safety regulator, ARPANSA. ANSTO acknowledges the Australian Government’s announcement on 10 August 2023 of the decision to not appeal the Federal Court’s judgment on the National Radioactive Waste Management Facility, nor to pursue Napandee or other previously shortlisted sites as a potential location for the facility. ANSTO also notes the Australian Government remains committed to its goal of safely storing and disposing radioactive waste in a permanent, purpose-built facility.

ANSTO will continue to support Government on alternative proposals for the storage and disposal of the Commonwealth’s civilian low-level and intermediate-level radioactive waste through the provision of expert advice and technical support.

Regulatory environment

ANSTO operates within a complex and highly regulated business environment with varying degrees of accountability to more than 30 regulators across international, federal, and state levels.

ANSTO’s main domestic regulators include:

4.1.6

Financial environment

ANSTO relies on a combination of government appropriations, grants, and commercial revenue to finance our operations.

For 2024-25, the Budget provided $318.4 million to support ANSTO’s achievement of its purpose, goals, and objectives, in addition to the $153.9 million forecast for our own source revenue, primarily from the sale of nuclear medicine and other activities. ANSTO is committed to ensuring the financial sustainability of its operations, including opportunities to grow our commercial revenue, using opportunities aligned with ANSTO’s strategy.

The 2024-25 Budget allocated ANSTO $25.9 million over two years from 2024-25 to continue production of affordable nuclear medicine.

In the Budget 2024-25 the remaining funding from Budget 2023-24 was released to ANSTO, over the period 2024-25 to 2032-33, for the construction of the new nuclear medicine manufacturing facility to replace the current facility

Achieving a sustainable operating budget remains a challenge that is being affected by both internal and external factors. ANSTO is responding to these challenges as we continue to identify further opportunities for commercial revenue.

Geographical factors

Australia’s climate continues to change with a prediction of warmer temperatures, reduced precipitation, and increased risk of drought. Extreme weather events including extreme temperatures and rainfall events, more frequent and intense fires, and susceptibility to sea-level rises have also been suggested.

ANSTO’s work contributes to a better understanding of the processes that shaped the climate and landscape and is critical to improve the predictions of future climate and environmental changes. ANSTO environmental researchers undertake targeted research to improve knowledge of past and present climate and the evolution of the landscape. ANSTO’s unique nuclear and isotopic techniques, complemented by geochemical and biological capabilities and combined with multidisciplinary expertise can provide new knowledge of complex environmental and climatic processes. This information can build Australia’s capacity to respond to changes in climate and the environment.

Sharing the peaceful application of nuclear science and technology for social and economic development

ANSTO is delivering on our international obligations and our international development policy. We implement the third pillar of the Treaty on the Non-Proliferation of Nuclear Weapons by sharing the peaceful uses of nuclear science and technology with the world. We develop professionals in our region in human health, environment, agriculture and industry. We bring together cancer care professionals from Australia to the Asia and Pacific region to improve diagnosis and treatment amongst our neighbours.

We led the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific as the Chair from May 2023 to May 2024 during which we advanced gender equality, strengthened governance, and trained 744 professionals through 15 regional training courses across 15 projects

Australia leads a project on combating food fraud, contributing to the region’s biosecurity through the Japan-led Forum for Nuclear Cooperation in Asia. ANSTO is sharing our food provenance technology platform to create a regional federated database focused on key priority food items which will advance authentic trade and support consumer confidence in our region.

Through these efforts, ANSTO is advancing the 2030 Agenda for Sustainable Development and its Sustainable Development Goals.

ANSTO’s global partnerships

ANSTO values its global partnerships which demonstrate leadership in best practice in nuclear science and technology capability across the globe. We have deep engagements, and continue to build strong relationships, with multilateral and bilateral partners. We have existing cooperative arrangements with a number of organisations and institutions internationally, and, more specifically, in the Asia-Pacific region.

Research and Development

. Universities

. Academics

. Industries

. Innovation Precincts

Government

. Local councils

. State

. Federal

. International agencies

. Regulatory bodies

Community/Education

. STEM education and outreach

. Indigenous engagement

. AINSE

Industry

. nandin innovation precinct

International

. Multilateral organisations

. International counterparts

Portfolio Budget Statements, Corporate Plan and Annual Report

Our Corporate Plan is our key strategic planning document. Our Annual Report measures our results against this Corporate Plan and the Portfolio Budget Statements (PBS).

Corporate Plan

Our Corporate Plan is our primary planning document, which outlines our purpose, strategy, performance measures, key activities, and capabilities over the next four years. As our primary planning document, the Corporate Plan includes the full set of performance measures endorsed by the ANSTO Board. These measures build and expand on the performance measures outlined in the PBS. s. 35 PGPA Act

Annual Report

Our Annual Report responds to certain legislative requirements regarding ANSTO’s finances, governance, performance, and activities during the previous financial year. It reports against the PBS and Corporate Plan. s. 46 PGPA Act

Portfolio Budget Statements (PBS)

Our PBS informs Parliament of the proposed allocation of resources to ANSTO. It is presented in the PBS for the Industry, Science, and Resources Portfolio.

Planning and measuring performance

Our integrated business planning (IBP) process provides an integrated framework for ANSTO employees to manage the operations of the organisation to ensure delivery on our purpose and strategy within this Corporate Plan. Our commitment to customers, partners, and stakeholders remains at the forefront of our planning activities.

Divisional and tactical implementation plans provide the foundation for the performance measures and key activities found within each strategic objective. Each of these performance measures and key activities are endorsed by our Group Executives.

The IBP process provides monthly check-ins on performance in alignment with our strategy through measurement against our performance measures on a rolling-24 months, etc.

ANSTO’s planning cycle responds to the requirements of the PGPA Act and has two cycles: planning and forecasting; and reporting and performance.

s. 36 PGPA Act and Appropriations Bills (No. 1 and No. 2)

Our subsidiaries

ANSTO subsidiaries and companies operate to enhance our capabilities, fulfil our purpose and strategy, and provide transitional arrangements as we reorganise our activities.

ANSTO Subsidiaries

PETTECH Solutions Pty Ltd

ANSTO Nuclear Medicine Pty Ltd

Jurisdiction of Operation Description

New South Wales

PETTECH Solutions Pty Ltd (PETTECH) is a wholly-owned ANSTO subsidiary which owns a cyclotron facility. On 2 January 2019, the operations of this company was sold to Cyclotek NSW Pty Ltd.

PETTECH Solutions Pty Ltd, remains the owner of the major facility assets (building, cyclotron, and hot cells) and is entitled to a share of profits from the Cyclotek NSW business in connection with this arrangement.

Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure.

(Strategic Objective 1)

New South Wales In Budget 2023-24 the Government announced its decision to formally wind up ANSTO Nuclear Medicine Pty Ltd (ANM) by 1 July 2024 and transfer its operations, assets and liabilities to ANSTO.

The operations, assets and liabilities of ANM were transferred to ANSTO effective 1 December 2023. The company was then placed into members voluntary liquidation and was deregistered on 21 May 2024.

As a result of the transfer ANSTO directly owns and operates:

. The ANM Molybdenum-99 (Mo-99) Manufacturing Facility, which produces one of the world’s most important nuclear medicines.

. When completed, a treatment plant for the alkaline waste produced from the production of Mo-99, using ANSTO’s Synroc® technology.

Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic, and innovative treatments for current and emerging diseases.

(Strategic Objective 2)

Governance and risk management

The risk factors outlined below provide an overview of our key strategic risks related to our strategy and operating environment. These risks influence the delivery of our strategic objectives and purpose.

Oversight of risk management

The Board retains overall accountability for the application and integrity of our systems of risk and control. Our Group Executives are accountable to the Board and are responsible for

implementing, monitoring, and continuously improving these risk management systems, and their integration into the day-today activities of the organisation.

Board-level Risk governance and oversight

Management-level Risk governance and oversight

The ANSTO Board retains overall accountability for the governance of risk. The Risk & Audit Committee is appropriately mandated to assist the Board in giving effect to its accountability. The Board receives regular updates via the Risk & Audit Committee on key risks. Measures relating to risk appetite and risk tolerance are considered and approved by the Board.

The Board delegates responsibility to implement and execute effective risk management to the Chief Executive and the Risk Oversight Committee (ROC).

Group Executives, as members of the ROC, are accountable for management of risks within their areas of responsibility, with delegated responsibility and ownership of their respective business areas.

Our Enterprise Risk Management (ERM) process

Our strategic risks are identified by considering our strategy and operating environment. We continue to ensure that we strengthen the link between our strategy and strategic risks by applying our ERM process in the context of our key business imperatives, which provide the basis for our strategic risks.

We continue to focus our risk management process on ensuring the adequacy, appropriateness and effectiveness of our responses to prevent and mitigate potential significant business impacts and to ensure delivery on our strategy.

Strategic risk informed by:

Strategy, internal and external operating context and key business imperatives

Key business imperatives:

Research and research infrastructure, commercial activities and expert advice

Identifying and reviewing strategic risks

Our key business imperatives, aligned with our strategy, guide and inform our strategic risks. We regularly review our strategic risks with due consideration of a dynamic internal and external operating environment. We benchmark our strategic risks against available global, industry and peer company risk views.

Assessing, managing and responding to strategic risks

We assess and understand the potential impact of our strategic risks in relation to ANSTO’s risk appetite and tolerance levels. We understand our capability to respond to our strategic risks by identifying and regularly reviewing the appropriateness and effectiveness of our responses.

Reporting on strategic risks

We report on our strategic risks to the relevant governance and oversight structures. We communicate and report significant risks to external stakeholders in accordance with statutory and regulatory requirements.

Our risk management process is iterative and applied in a dynamic operating context

Risk management governance and assurance

We have governance and oversight structures at Board and management level and combined assurance arrangements to provide assurance on our strategic risks and risk management processes in line with a five lines of defence model.

Applying our ERM process to identify, assess, manage, govern, assure and report on our strategic risks, and respond to increased and emerging risks being faced in the short, medium and long term.

Enterprise Risk Management Process

Strategic risks

RISK THEMES AND FACTORS

Financial

. Fluctuations in own source revenue and exchange rates may adversely affect our financial outcome.

We may not achieve our cash management targets.

OUR KEY RESPONSES

Management has reviewed all aspects of operational expenditure to identify cost reduction options, with a view to achieving a sustainable operating budget from FY23 and beyond.

. We have a two-year rolling forecast which enables us to minimise the impact of fluctuations and to respond earlier when fluctuations are identified.

. Exploring and pursuing viable revenue-generating opportunities.

Capital expenditure/ investments

. Our major projects are subject to schedule delays and cost overruns, and we may face material changes in market conditions or other business assumptions which could have a negative effect on the delivery of our projects, on time and on budget.

Safety and operations

. Our operations are subject to operating risks (e.g., accidents resulting in injury or the loss of life or property; environmental incidents; mechanical or design failures), which could result in significant operational impacts (e.g., inability to supply Mo-99 and/or medical isotope generators), regulatory non-compliance and legal claims for compensation.

. Management has established a Capital Committee and an ANSTO Capital Program Management Office. This provides an additional layer of governance and oversight for our key projects.

ANSTO seeks to attract, develop and retain skilled employees through:

. All operations are underpinned by a comprehensive WHS management system that is accredited to ISO 45001.

. We embed subject matter experts (SMEs) at the design phase of projects.

. SMEs support ANSTO activities through a prioritised approach in-line with our ANSTO strategy.

There is an assurance process involving relevant SMEs for identified high-risk activities.

. An ongoing program of works addresses legacy hazards including asbestos and electrical hazards.

. A deep dive safety culture audit process has been developed that meets international best practice and is implemented across site.

RISK THEMES AND FACTORS

Stakeholders

. A decline in stakeholder confidence in our ability to deliver on our mandate could result in damage to ANSTO’s reputation and, reduced demand for our products or services.

OUR KEY RESPONSES

Our engagement approach is based on open and effective communication and mutually beneficial outcomes where possible, as well as inclusiveness and integrity.

. Various processes are in place to proactively engage with stakeholders and to mitigate associated risks.

. ANSTO’s engagement strategy and key messages have been endorsed by the Board and Executive.

. ANSTO manages or participates in numerous committees and forums of the Australian Government, with participation contributing to stakeholder management, external messaging, risk identification/mitigation, and opportunity development.

. ANSTO is the implementing agent for Australian participation in numerous international forums and projects, which helps to strengthen ANSTO’s relationships with key nuclear organisations and associations, with attendant reputational enhancement in Australia.

Market

. Increasing competition in the radiopharmaceutical market may have a negative effect on our business and financial condition.

. Our strategy includes development and commercialisation of new technologies which may require significant investment and involves various risks and uncertainties.

. We proactively work with customers to ensure ANSTO is a preferred supplier through achieving service targets

. With NTP Radioisotopes, a South African based global producer and supplier of nuclear medicine and radiation-based products and services, we leverage market supply and demand dynamics to diversify our source of export revenue (ongoing) for Mo-99.

We leverage I-131 market dynamics to grow local share and leverage excess capacity to grow export revenue.

. We are seeking to expand Lu-177 production runs to two enabling ANSTO to meet growing local demand with excess capacity being made available for export.

People

. We may not be successful in attracting, developing, and retaining sufficiently or appropriately skilled employees.

ANSTO seeks to attract, develop and retain skilled employees through:

early careers pathways – graduates, apprentices;

. training and development programs;

. a rigorous talent and succession process;

. employee engagement surveys;

. utilising contractors appropriately for short term work and capital programs where expertise is required.

utilising individual contracts for senior and specialist staff, enabling closer to market remuneration; and

. Science in Australia Gender Equity (SAGE) accreditation.

RISK THEMES AND FACTORS

Information technology

. We may face information security breaches or attempts to disrupt critical IT services, which may adversely impact our operations.

KEY RESPONSES

ANSTO Systems Security Plan, focuses on prevention, detection, and containment through network security controls, intrusion detection, anti-virus, firewalling, logging, and monitoring providing defence in depth.

. We run scheduled routine patching on both core production servers and non-legacy endpoints.

. ANSTO follows the information security governance standards: Australian Government Information Security Manual and IAEA guidance.

. We leverage cybersecurity services available through the Information Security Registered Assessors Program (IRAP) of the Australian Signals Directorate (ASD).

ANSTO invests in the development of key people capabilities.

. Legacy systems are decommissioned.

Appendix

List of requirements

This Corporate Plan has been prepared in accordance with the requirements of:

. s 35(1)(b) of the Public Governance, Performance and Accountability Act 2013 (PGPA Act)

. Public Governance, Performance and Accountability Rule 2014 (PGPA Rule)

. RMG-132 Corporate Plan for Commonwealth entities

These are the required sections and the page reference(s) that show how our corporate plan meets these expectations:

Introduction

The Corporate Plan must include an introductory statement that:

(i) states that the plan has been prepared for paragraph 35(1)(b) of the PGPA Act;

(ii) specifies the reporting period for which the plan is prepared;

(iii) specifies the reporting periods covered by the plan (this would usually be the minimum four-year period covered by the Plan).

The Corporate Plan must include the purpose(s) of the entity. The purposes of an entity include the objectives, functions or role of the entity. 8,

Key activities

The Corporate Plan must identify the key activities that an entity will undertake during the entire period of the Corporate Plan in order to achieve the purposes of the entity.

The Corporate Plan must set out the details of how an entity’s performance in achieving its purposes will be measured and assessed for each reporting period covered by the plan. 14, 23, 25, 27, 31, 33, 34-35, 37-38, 44

Glossary

TERM DESCRIPTION

ACNS Australian Centre for Neutron Scattering

ADS 1&2 Advanced Diffraction and Scattering beamlines

AINSE Australian Institute of Nuclear Science and Engineering

ANSTO Australian Nuclear Science and Technology Organisation

ANSTO Act Australian Nuclear Science and Technology Organisation Act 1987

ANM ANSTO Nuclear Medicine

ARPANSA Australian Radiation and Protection and Nuclear Safety Agency

ASD Australian Signals Directorate

AUKUS Australia, United Kingdom, United States

BioSAXS Small Angle X-ray Scattering beamline

CAS Centre for Accelerator Science

CEO Chief Executive Officer

CSIRO Commonwealth Scientific and Industrial Research Organisation

DIFOT Delivery in full, on time

EPBC Act Environment Protection and Biodiversity Conservation Act 1999 (Cth)

ESD Ecologically sustainable development

FNCA Forum for Nuclear Cooperation in Asia

FOI Freedom of Information Act 1982

FTE Full time equivalent

GIF Generation IV International Forum

IAEA International Atomic Energy Agency

ISO International Organisation for Standardisation

ITER ITER is the world's largest fusion experiment

ITRAX X-ray fluorescence scanning instrument

LGBTQIA+ Lesbian, Gay, Bisexual, Transgender, Queer (or questioning), Intersex, and Asexual (or allies).

TERM DESCRIPTION

MCT Microcomputed Tomography Beamline

MEX 1&2 Medium Energy X-ray Absorption Spectroscopy beamlines

Mo-99 Molybdenum-99

MX3 Micro Crystallography beamline

NACC Nuclear Agencies Consultative Committee

NANO Nanoprobe beamline

NCRIS National Collaborative Research Infrastructure Strategy

NEA Nuclear Energy Agency (OECD)

NMMF Nuclear Medicine Manufacturing Facility

NTD Neutron transmutation doped

OECD Organisation for Economic Cooperation and Development

OFI Opportunities for improvement

OPAL Open Pool Australian Light-water

PGPA Act Public Governance, Performance and Accountability Act 2013 (Cth)

PFAS Per and poly-fluoroalkyl substances

RAC Risk and Audit Committee

RCA Regional Cooperative Agreement for Research, Development and Training related to Nuclear Science and Technology in Asia and the Pacific

RAM Regional Agencies Meeting

RAP Reconciliation Action Plan

RMIT Royal Melbourne Institute of Technology

STA Science and Technology Australia

STEM Science, technology, engineering, and mathematics

UNSW University of New South Wales

UoM University of Melbourne

UoW University of Wollongong

Contact details

ANSTO – Sydney

New Illawarra Rd

Lucas Heights

NSW 2234

Phone: +61 2 9717 3111

ANSTO – Melbourne

800 Blackburn Rd

Clayton VIC 316

Email: enquiries@ansto.gov.au

Website: www.ansto.gov.au

Vienna Counsellor (Nuclear)

Australian Embassy

Mattiellistrasse 2-4 A-1040

Vienna, Austria

Phone: +43 699 13550400

Email: marina.francis@dfat.gov.au